Endoscopy Fluid Management Systems Market Expected To Rise at a Modest CAGR of 6.6% by 2026, Estimates DelveInsight

Endoscopy Fluid Management Systems market is expected to rise due to an increasing occurrence of chronic diseases, and escalating preferences for minimally invasive procedures globally.

LAS VEGAS, April 29, 2021 /PRNewswire/ -- DelveInsight's Endoscopy Fluid Management Systems Market Insights, Competitive Landscape and Market Forecast -2026 provides the current and forecast market of the Endoscopy Fluid Management Systems and comprises of market trends and key competitors of Endoscopy Fluid Management Systems. DelveInsight estimated the market to grow at a steady CAGR over the study period of 2018 – 2026. 

Key Highlights of Endoscopy Fluid Management Systems Market report:

• Endoscopy helps surgeons and clinicians to properly diagnose and perform surgery for various chronic and acute diseases. During the procedure, both internal and external surfaces of endoscopes are exposed to body fluids. The need for an endoscopy fluid management system arose due to the presence of body fluids that hinder the proper working of these endoscopes.
• The market is segmented by application type, by modality type, and by end-user.
• In terms of market share by application type, it has been seen that the systems are being majorly used for Hysteroscopy (45%) followed by Laparoscopy and Arthroscopy.
• In terms of modality type of these systems, the market is dominated by Bench Top model because of the ease they provide to surgeons while performing endoscopy.
• The majority of surgery using endoscopy is performed in hospitals therefore the market of end user is taken up by Hospitals, and the rest of the market share is divided between Ambulatory Surgical Centers and Diagnostic Centers.
• According to the estimates, the highest contribution in the market size of Endoscopy Fluid Management Systems is from the United States (89.06%) among the seven major markets.
• On December 7, 2020, Cantel Medical Corp and Censis Technologies announced a new long-term partnership to combine Cantel's leading infection prevention endoscope reprocessing workflow portfolio with the surgical asset management and instrument tracking solutions from Censis. This is expected to increase the market share of Cantel Medical Corp.
• The Stryker CrossFlow Integrated Arthroscopy Pump was approved by the FDA on July 12, 2019. This product is CE marked according to the European Medical Device Directive.

Request for Sample @ Endoscopy Fluid Management Systems Market

Endoscopy Fluid Management Systems Market

Endoscopic procedures are minimally invasive procedure therefore they are widely used in diagnosis of various diseases of gastrointestinal tract, respiratory tract, ear, urinary tract and female reproductive tract. There was an estimated 75 million endoscopies performed annually in the United States.

Endoscopy is the most commonly performed gastrointestinal procedure in Europe as well. In the United Kingdom there are around 2 million procedures performed each year. Around 500 endoscopy units are registered with the Joint Advisory Group on GI Endoscopy (JAG).

As per the study published in the Journal of Obstetrics and Gynecology Research, the numbers of endoscopic surgeries conducted in 2016 were 67, 000 laparoscopic, 13, 000 hysteroscopic and 450 falloposcopic in Japan.

The EndoMat fluid management system (Karl Storz Se & Co. Kg), CrossFlow Integrated Arthroscopy Pump (Stryker), and Fluent Fluid Management Systems (Hologic Inc.) are some endoscopic fluid management systems that have been recently approved. Most of the available devices are CE marked.

The Endoscopy Fluid Management Systems Market is driven by rising demand of endoscopies in various fields such as gastroenterology, urology, dentistry, gynecology, neurology, arthroscopy, laparoscopy, cardiology, bronchoscopy, and others. The increasing prevalence gastrointestinal cancer due to sedentary and erratic lifestyles along with unhealthy diet habits and increasing adoption of minimally invasive procedures are factors responsible for the growth of the endoscopy fluid management systems market size at a high CAGR during the forecast period.

Key Competitors in the Endoscopy Fluid Management Systems Market:

• Arthrex Inc.
• B. Braun
• Cantel Medical Systems
• Comeg Medical Technologies
• Conmed corporation
• Endomed Systems
• Fujifilm Corporation
• Gimmi GmbH
• Hologic Inc.
• Johnson & Johnson
• KARL STORZ SE & Co. KG
• Medtronic Inc.
• Olympus Medical Corporation
• Richard Wolf Company
• Serres
• Smith & Nephew
• Steris
• Stryker
• Thermedx
• Vimex Sp. z o.o.

Know more about the key companies involved @ Endoscopy Fluid Management Systems Market Key Companies

Table of Content

Visit to know more about the report offerings @ Endoscopy Fluid Management Systems Market

The report provides valuable insight for clients venturing into the endoscopy fluid management systems and acts as the source of guidance for taking strategic business decisions in the field of endoscopy fluid management systems by providing a descriptive overview of endoscopy fluid management systems and application, including detailed chapters on type of products.

Along with this, the Endoscopy Fluid Management Systems Market report has a detailed review of the market containing historical and forecasted market size in 7MM, by understanding the trends shaping and driving the global endoscopy fluid management systems.

This report has been prepared by DelveInsight's analysts after a thorough secondary and primary research into the endoscopy fluid management systems market. Analysis and estimations are done by taking into consideration the share of topmost companies and industry expert viewpoints of endoscopy fluid management systems.

Related Reports

Airway Management Devices Market

DelveInsight's 'Airway Management Devices -Market Insights, Competitive Landscape and Market Forecast - 2025' report delivers an in-depth comprehensive insights into key companies including Medtronic, Teleflex, Ambu A/S, Smiths Medical, Medline Industries, and others.

Deep Brain Stimulation Devices Market

DelveInsight's 'Deep Brain Stimulation Devices -Market Insights, Competitive Landscape and Market Forecast - 2025' report provides comprehensive insights into key companies including Boston Scientific Corporation, Medtronic, Inc., St. Jude Medical, Inc. (Abbott Laboratories), Cyberonics, Inc., Neuronetics, Aleva Neurotherapeutics SA., Functional Neuromodulation Ltd., Beijing PINS Medical Co., Ltd., NeuroPace Inc., Nevro Corporation, and several others.

Arteriotomy Closure Devices Market

DelveInsight's 'Arteriotomy Closure Devices -Market Insights, and Market Forecast - 2025' report provides comprehensive insights into key companies including Abbott Vascular, Cardiva Medical, Arstatis, Cardinal Health, St. Jude Medical, Morris Innovative Research, and Scion BioMedical., and several others.

Vagus Nerve Stimulator Market

DelveInsight's 'Vagus Nerve Stimulator (VNS)-Market Insights, and Market Forecast-2025' report provides a comprehensive analysis of epidemiology, therapies and key companies including tVNS Technologies, Parasym Ltd., BioControl Medical, ElectroCore Inc., LivaNova PLC, Medtronic Plc., Boston Scientific Corporation, Aleva Neurotherapeutics SA, EnteroMedics Inc., and several others.

Cardiac Biomarkers Testing Devices Market

DelveInsight's 'Cardiac Biomarkers Testing Devices Market and Market Forecast-2025' report provides a comprehensive analysis of epidemiology, therapies and key companies including F. Hoffmann-La Roche Ltd, Abbott, Siemens Healthcare Private Limited, Danaher, bioMérieux, Inc., Ortho Clinical Diagnostics, Randox Laboratories Ltd, BG Medicine, Inc., HUMAN, Bhat Bio-tech India Private Limited, DIALAB GmbH, Beckman Coulter, Inc, Thermo Fisher Scientific, Tosoh Corporation, PerkinElmer Inc. and Johnson & Johnson Services, Inc., and several others.

ABSSSI Market and Pipeline 

Comprehensive insights into epidemiology, therapies and key pharmaceutical companies including Innovation Pharmaceuticals, Motif Bio, Basilea Pharmaceutica, Debiopharm, Destiny Pharma, KBP Biosciences, MicuRx Pharmaceuticals, and several others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.  Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Get in-depth knowledge of the healthcare and pharma world, licensing solutions and services @ DelveInsight's Licensing Services.

For more insights, visit Pharma, Healthcare, and Biotech News. 

Contact Us:
Shruti Thakur 
info@delveinsight.com 
+1(919)321-6187 
www.delveinsight.com

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg